Relapse after bone marrow transplantation: Evidence for distinct immunological mechanisms between adult and paediatric populations

British Journal of Haematology

Volumn 109, Issue 1, 2000, Pages 130-137

  Guimond, Martin ^a   Busque, Lambert ^a   Baron, Chantal ^a   Bonny, Yvette ^a   Bélanger, Robert ^a   Mattioli, Johanne ^a   Perreault, Claude ^a   Roy, Denis Claude ^a  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

Bone marrow transplantation; Leukaemia; Mixed chimaerism; NK cells; T cells

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; CELL LOSS; CHILD; CHIMERA; FEMALE; HEMATOPOIETIC SYSTEM TUMOR; HUMAN; INFANT; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; T LYMPHOCYTE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHIMERA; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOPHENOTYPING; INFANT; KILLER CELLS, NATURAL; LEUKEMIA; MALE; MIDDLE AGED; RECURRENCE; T-LYMPHOCYTES; TANDEM REPEAT SEQUENCES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0034074746     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.01961.x     Document Type: Article

References (37)

1. Alyea, E.P., Soiffer, R.J., Canning, C., Neuberg, D., Schlossman, R., Pickett, C., Collins, H., Wang, Y., Anderson, K.C. & Ritz, J. (1998) Toxicity and efficacy of defined doses of CD4 (+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant. Blood, 91, 3671-5680.
2. Bader, P., Holle, W., Klingebiel, T., Handgretinger, R., Benda, N., Schlegel, P.G., Niethammer, D. & Beck, J. (1997) Mixed hematopoietic chimaerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children. Bone Marrow Transplantation, 19, 697-702.
3. Bader, P., Beck, J., Frey, A., Schlegel, P.G., Hebarth, H., Handgretinger, R., Einsele, H., Niemeyer, C., Benda, N., Faul, C., Kanz, L., Niethammer, D. & Klingebiel, T. (1998) Serial and quantitative analysis of mixed hematopoietic chimaerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT. Bone Marrow Transplantation, 21, 487-495.
4. von Bueltzingsloewen, A., Belanger, R., Perreault, C., Bonny, Y., Roy, D.C., Lalonde, Y., Boileau, J., Kassis, J., Lavallee, R. & Lacombe, M. (1993) Acute graft-versus-host disease prophylaxis with methotrexate and cyclosporin after busulfan and cyclophosphamide in patients with hematologic malignancies. Blood, 81, 849-855.
5. Desbarats, J. & Lapp, W.S. (1993) Thymic selection and thymic major histocompatibility complex class II expression are abnormal in mice undergoing graft-versus-host reactions. Journal of Experimental Medicine, 178, 805-814.
6. Dey, B.R., Yang, Y.G., Szot, G.L., Pearson, D.A. & Sykes, M. (1998) Interleukin-12 inhibits graft-versus-host disease through a Fas-mediated mechanism associated with alterations in donor T-cell activation and expansion. Blood, 91, 3515-3322.
7. Dulude, G., Brochu, S., Fontaine, P., Baron, C., Gyger, M., Roy, D.C. & Perreault, C. (1997) Thymic and extrathymic differentiation and expansion of T lymphocytes following bone marrow transplantation in irradiated recipients. Experimental Hematology, 25, 992-1004.
8. Dulude, G., Roy, D.C. & Perreault, C. (1999) The effect of graft-versus-host disease on T cell production and homeostasis. Journal of Experimental Medicine, 189, 1329-1342.
9. Ehl, S., Aichele, P., Ramseier, H., Barchet, W., Hombach, J., Pircher, H., Hengartner, H. & Zinkernagel, R.M. (1998) Antigen persistence and time of T-cell tolerization determine the efficacy of tolerization protocols for prevention of skin graft rejection. Nature Medicine, 4, 1015-1019.
10. Foroni, L., Harrison, C.J., Hoffbrand, A.V. & Potter, M.N. (1999) Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis. British Journal of Haematology, 105, 7-24.
11. Glass, B., Uharck, L., Zeis, M., Loeffler, H., Mueller-Ruchholtz, W. & Gassmann, W. (1996) Graft-versus-leukaemia activity can be predicted by natural cytotoxicity against leukaemia cells. British Journal of Haematology, 93, 412-420.
12. Goldman, J.M., Gale, R.P., Horowitz, M.M., Biggs, J.C., Champlin, R.E., Gluckman, E., Hoffmann, R.G., Jacobsen, S.J., Marmont, A.M. & McGlave, P.B. (1988) Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. Annals of Internal Medicine, 108, 806-814.
13. Gyger, M., Baron, C., Forest, L., Lussier, P., Lagace, F., Bissonnette, I., Belanger, R., Bonny, Y., Busque, L., Roy, D.C. & Perreault, C. (1998) Quantitative assessment of hematopoietic chimaerism after allogeneic bone marrow transplantation has predictive value for the occurrence of irreversible graft failure and graft-vs.-host disease. Experimental Hematology, 26, 426-434.
14. Heitger, A., Neu, N., Kern, H., Panzer-Grumayer, E.R., Greinix, H., Nachbaur, D., Niederwieser, D. & Fink, F.M. (1997) Essential role of the thymus to reconstitute naive (CD45RA+) T-helper cells after human allogeneic bone marrow transplantation. Blood, 90, 850-857.
15. Hermans, I.F., Daish, A., Yang, J., Ritchie, D.S. & Ronchese, F. (1998) Antigen expressed on tumor cells fails to elicit an immune response, even in the presence of increased numbers of tumor-specific cytotoxic T lymphocyte precursors. Cancer Research, 58, 3909-3917.
16. Huss, R., Deeg, H.J., Gooley, T., Bryant, E., Leisenring, W., Clift, R., Buckner, C.D., Martin, P., Storb, R. & Appelbaum, F.R. (1996) Effect of mixed chimaerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia. Bone Marrow Transplantation, 18, 767-776.
17. Kolb, H.J., Schattenberg, A., Goldman, J.M., Hertenstein, B., Jacobsen, N., Arcese, W., Ljungman, P., Ferrant, A., Verdonck, L. & Niederwieser, D. (1995) Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party on Chronic Leukemia. Blood, 86, 2041-2050.
18. Kusunoki, Y., Chen, W. & Martin, P.J. (1998) Prevention of marrow graft rejection without induction of graft-versus-host disease by a cytotoxic T-cell clone that recognizes recipient alloantigens. Blood, 91, 4038-4044.
19. van Leeuwen, J.E.M., van Tol, M.J., Joosten, A.M., Wijnen, J.T., Khan, P.M. & Vossen, J.M. (1993) Mixed T-lymphoid chimaerism after allogeneic bone marrow transplantation for hematologic malignancies of children is not correlated with relapse. Blood, 82, 1921-1928.
20. van Leeuwen, J.E.M., van Tol, M.J., Joosten, A.M., Wijnen, J.T., Verweij, P.J., Khan, P.M. & Vossen, J.M. (1994) Persistence of host-type hematopoiesis after allogeneic bone marrow transplantation for leukemia is significantly related to the recipient's age and/or the conditioning regimen, but it is not associated with an increased risk of relapse. Blood, 83, 3059-3067.
21. Leonard, B.M., Hetu, F., Busque, L., Gyger, M., Belanger, R., Perreault, C. & Roy, D.C. (1998) Lymphoma cell burden in progenitor cell grafts measured by competitive polymerase chain reaction: less than one log difference between bone marrow and peripheral blood sources. Blood, 91, 331-339.
22. Lin, F., van Rhee, F., Goldman, J.M. & Cross, N.C. (1996) Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation. Blood, 87, 4473-4478.
23. Mackall, C.L. & Gress, R.E. (1997) Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapy. Immunological Review, 157, 61-72.
24. Mackinnon, S., Barnett, L., Heller, G. & O'Reilly, R.J. (1994) Minimal residual disease is more common in patients who have mixed T-cell chimaerism after bone marrow transplantation for chronic myelogenous leukemia. Blood, 83, 3409-3416.
25. Mackinnon, S., Papadopoulos, E.B., Carabasi, M.H., Reich, L., Collins, N.H., Boulad, F., Castro-Malaspina, H., Childs, B.H., Gillio, A.P., Kernan, N.A., Small, T.N., Young, J.W. & O'Reilly, R.J. (1995) Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. Blood, 86, 1261-1268.
26. Molloy, K., Goulden, N., Lawler, M., Cornish, J., Oakhill, A., Pamphilon, D., Potter, M., Steward, C., Langlands, K., Humphries, P. & McCann, S.R. (1996) Patterns of hematopoietic chimaerism following bone marrow transplantation for childhood acute lymphoblastic leukemia from volunteer unrelated donors. Blood, 87, 3027-3031.
27. Mutis, T., Schrama, E., van Luxemburg-Heijs, S.A., Falkenburg, J.H., Melief, C.J. & Goulmy, E. (1997) HLA class II restricted T-cell reactivity to a developmentally regulated antigen shared by leukemic cells and CD34+ early progenitor cells. Blood, 90, 1083-1090.
28. Palka, G., Stuppia, L., Di Bartolomeo, P., Morizio, E., Peila, R., Franchi, P.G. & Calabrese, G. (1996) FISH detection of mixed chimaerism in 33 patients submitted to bone marrow transplantation. Bone Marrow Transplantation, 17, 231-236.
29. Perreault, C., Roy, D.C. & Fortin, C. (1998) Immunodominant minor histocompatibility antigens: the major ones. Immunology Today, 19, 69-74.
30. Pichert, G., Alyea, E.P., Soiffer, R.J., Roy, D.C. & Ritz, J. (1994) Persistence of myeloid progenitor cells expressing BCR-ABL mRNA after allogeneic bone marrow transplantation for chronic myelogenous leukemia. Blood, 84, 2109-2114.
31. Pichert, G., Roy, D.C., Gonin, R., Alyea, E.P., Belanger, R., Gyger, M., Perreault, C., Bonny, Y., Lerra, I. & Murray, C. (1995) Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia. Journal of Clinical Oncology, 13, 1704-1713.
32. Roy, D.C., Tantravahi, R., Murray, C., Dear, K., Gorgone, B., Anderson, K.C., Freedman, A.S., Nadler, L.M. & Ritz, J. (1990) Natural history of mixed chimaerism after bone marrow transplantation with CD6-depleted allogeneic marrow: a stable equilibrium. Blood, 75, 296-304.
33. Slavin, S., Naparstek, E., Nagler, A., Ackerstein, A., Samuel, S., Kapelushnik, J., Brautbar, C. & Or, R. (1996) Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. Blood, 87, 2195-2204.
34. Smyth, M.J., Krasovskis, E., Sutton, V.R. & Johnstone, R.W. (1998) The drug efflux protein. P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis. Proceedings of the National Academy of Sciences of the United States of America, 95, 7024-7029.
35. Strand, S., Hofmann, W.J., Hug, H., Muller, M., Otto, G., Strand, D., Mariani, S.M., Stremmel, W., Krammer, P.H. & Galle, P.R. (1996) Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - a mechanism of immune evasion? Nature Medicine, 2, 1361-1366.
36. Weisdorf, D.J., Billett, A.L., Hannan, P., Ritz, J., Sallan, S.E., Steinbuch, M. & Ramsay, N.K. (1997) Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia. Blood, 90, 2962-2968.
37. Yeager, A.M., Wagner, J.E.J., Graham, M.L., Jones, R.J., Santos, G.W. & Grochow, L.B. (1992) Optimization of busulfan dosage in children undergoing bone marrow transplantation: a pharmacokinetic study of dose escalation. Blood, 80, 2425-2428.